Table 2.
Prevalence of respiratory and neurological sequelae in patients who have suffered COVID-19.
| Respiratory sequelae | |||||||
|---|---|---|---|---|---|---|---|
| At discharge |
1 month |
3 months | 6 months |
||||
| Acute episode severity | Severe | Not severe | Severe | Not severe | Severe | Not severe | |
| DLCO decrease <80% (%) | 84.21 | 38.5 | 76.5 | 42.5 | 16.4 | 56 | 22 |
| Restrictive Pattern (%) | 10.5−47.3 | 8.8−19.8 | 23.5 | 5−7.5 | 7.3−10.9 | 1−11 | 3 |
| Obstructive Pattern (%) | 0 | 5.5 | 10.5 | – | 2−8 | 8 | |
| At least one CT abnormality (%) | – | 94.1 | 37.5 | 70.91 | 54 | 52 | |
| 6-minute walk test (m [CI]) | – | 517.43 (472.9−562) | 573.52 (535.14−611.9) | – | 479 (434.0−515.5) | 495.0 (440.0–538) | |
| Neurological sequelae | ||
|---|---|---|
| 6 months |
||
| Non-hospitalized | ICU | |
| Hemorrhagic stroke (%) | 0.31 | 2.66 |
| Ischemic stroke (%) | 0.14 | 1.05 |
| Guillain barre (%) | 0.05 | 0.33 |
| Neuropathy, plexopathy, radiculopathy (%) | 2.69 | 4.24 |
| Myopathy (%) | 0.16 | 3.35 |
| Encephalitis (%) | 0.05 | 0.35 |
| Delirium (%) | 0.35 | 1.74 |
| 2 months | 6 months | |
| Anosmia/ageusia (%) | 12−32.6 | 24 |
CVA: cerebrovascular accident (stroke); DLCO: decreased diffusion capacity; CI: confidence interval; CT: computed tomography; ICU: Intensive care unit.